NeoGenomics, Inc. Restructuring Costs
NeoGenomics, Inc. (NEO) reported Restructuring Costs of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2025-10-28
- NeoGenomics, Inc. restructuring costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- NeoGenomics, Inc. restructuring costs for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- NeoGenomics, Inc. restructuring costs for the quarter ending 2024-09-30 was $1.01M.
- NeoGenomics, Inc. restructuring costs for the quarter ending 2024-06-30 was $1.54M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month |
|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-10-28 | $0.00 derived: sum of 2 quarters · filed 2025-10-28 | $0.00 10-Q · filed 2025-10-28 |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-29 | $0.00 10-Q · filed 2025-07-29 | |
| 2024-09-30 | $1.01M 10-Q · filed 2025-10-28 | $2.55M derived: sum of 2 quarters · filed 2025-10-28 | $4.95M 10-Q · filed 2025-10-28 |
| 2024-06-30 | $1.54M 10-Q · filed 2025-07-29 | $3.94M 10-Q · filed 2025-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |